Spruce Biosciences
Biotechnology ResearchCalifornia, United States11-50 Employees
Spruce Biosciences is a clinical stage biopharmaceutical company focused on developing novel therapies for rare diseases affecting the endocrine system.
Rare Disease Focus Spruce Biosciences specializes in novel therapies for rare endocrine diseases, presenting a unique value proposition to targeted healthcare providers and patients.
Financial Stability With reported funding of $54 million and revenue in the range of $0-10 million, Spruce Biosciences showcases financial stability, potentially indicating willingness to invest in innovative solutions.
Increased Employee Expansion With a workforce of 11-50 employees, Spruce Biosciences is poised for growth, suggesting potential scalability of operations and an expanding customer base for new partnerships.
Biotech Landscape Niche Within the competitive landscape, Spruce Biosciences occupies a niche segment alongside companies like Calithera and Zosano Pharma, presenting opportunities for targeted market positioning and differentiation.
Strategic Technology Adoption Utilizing tech tools such as UserWay, Yoast SEO, and Facebook, Spruce Biosciences demonstrates a forward-thinking approach that aligns with modern healthcare marketing strategies, enabling potential collaboration on digital solutions.
Spruce Biosciences uses 8 technology products and services including UserWay, Adobe Fonts, Google Font API, and more. Explore Spruce Biosciences's tech stack below.
Spruce Biosciences Email Formats | Percentage |
FLast@sprucebiosciences.com | 79% |
First@sprucebiosciences.com | 10% |
Last@sprucebiosciences.com | 7% |
First.Last@sprucebiosciences.com | 4% |
Biotechnology ResearchCalifornia, United States11-50 Employees
Spruce Biosciences is a clinical stage biopharmaceutical company focused on developing novel therapies for rare diseases affecting the endocrine system.
Spruce Biosciences has raised a total of $54M of funding over 3 rounds. Their latest funding round was raised on Feb 09, 2023 in the amount of $54M.
Spruce Biosciences's revenue is in the range of $10M
Spruce Biosciences has raised a total of $54M of funding over 3 rounds. Their latest funding round was raised on Feb 09, 2023 in the amount of $54M.
Spruce Biosciences's revenue is in the range of $10M